Hu Xi-Min, Zheng Shengyuan, Zhang Qi, Wan Xinxing, Li Ji, Mao Rui, Yang Ronghua, Xiong Kun
Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China.
Department of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha 410013, China.
Comput Struct Biotechnol J. 2023 Nov 28;23:64-76. doi: 10.1016/j.csbj.2023.11.049. eCollection 2024 Dec.
Accumulating evidence suggests that regulated cell death, such as pyroptosis, apoptosis, and necroptosis, is deeply involved in the pathogenesis of psoriasis. As a newly recognized form of systematic cell death, PANoptosis is involved in a variety of inflammatory disorders through amplifying inflammatory and immune cascades, but its role in psoriasis remains elusive.
To reveal the role of PANoptosis in psoriasis for a potential therapeutic strategy.
Multitranscriptomic analysis and experimental validation were used to identify PANoptosis signaling in psoriasis. RNA-seq and scRNA-seq analyses were performed to establish a PANoptosis-mediated immune response in psoriasis, which revealed hub genes through WGCNA and predicted disulfiram as a potential drug. The effect and mechanism of disulfiram were verified in imiquimod (IMQ)-induced psoriasis.
Here, we found a highlighted PANoptosis signature in psoriasis patients through multitranscriptomic analysis and experimental validation. Based on this, two distinct PANoptosis patterns (non/high) were identified, which were the options for clinical classification. The high-PANoptosis-related group had a higher response rate to immune cell infiltration (such as M1 macrophages and keratinocytes). Subsequently, WGCNA showed the hub genes (e.g., , , , , , , ), which were significantly associated with clinical phenotype, PANoptosis signature, and identified immune response in psoriasis. Finally, we explored disulfiram (DSF) as a candidate drug for psoriasis through network pharmacology, which ameliorated IMQ-mediated psoriatic symptoms through antipyroptosis-mediated inflammation and enhanced apoptotic progression. By analyzing the specific ligand-receptor interaction pairs within and between cell lineages, we speculated that DSF might exert its effects by targeting keratinocytes directly or targeting M1 macrophages to downregulate the proliferation of keratinocytes.
PANoptosis with its mediated immune cell infiltration provides a roadmap for research on the pathogenesis and therapeutic strategies of psoriasis.
越来越多的证据表明,程序性细胞死亡,如细胞焦亡、凋亡和坏死性凋亡,与银屑病的发病机制密切相关。作为一种新认识的系统性细胞死亡形式,泛凋亡通过放大炎症和免疫级联反应参与多种炎症性疾病,但其在银屑病中的作用仍不清楚。
揭示泛凋亡在银屑病中的作用,以寻找潜在的治疗策略。
采用多转录组分析和实验验证来鉴定银屑病中的泛凋亡信号。进行RNA测序和单细胞RNA测序分析,以建立银屑病中泛凋亡介导的免疫反应,通过加权基因共表达网络分析(WGCNA)揭示核心基因,并预测双硫仑为潜在药物。在咪喹莫特(IMQ)诱导的银屑病中验证双硫仑的作用效果及机制。
在此,我们通过多转录组分析和实验验证,在银屑病患者中发现了突出的泛凋亡特征。基于此,确定了两种不同的泛凋亡模式(非/高),可作为临床分类的依据。高泛凋亡相关组对免疫细胞浸润(如M1巨噬细胞和角质形成细胞)的反应率更高。随后,WGCNA显示了核心基因(如 、 、 、 、 、 ),这些基因与临床表型、泛凋亡特征以及银屑病中确定的免疫反应显著相关。最后,我们通过网络药理学探索双硫仑(DSF)作为银屑病的候选药物,它通过抗细胞焦亡介导的炎症和增强凋亡进程改善了IMQ介导的银屑病症状。通过分析细胞谱系内和细胞谱系间的特异性配体-受体相互作用对,我们推测DSF可能通过直接靶向角质形成细胞或靶向M1巨噬细胞来下调角质形成细胞的增殖发挥作用。
泛凋亡及其介导的免疫细胞浸润为银屑病发病机制和治疗策略的研究提供了方向。